Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks.

Squires, Kathleen E; Young, Benjamin; Santiago, Lizette; Dretler, Robin H; Walmsley, Sharon L; Zhao, Henry H; Pakes, Gary E; Ross, Lisa L; Shaefer, Mark S

Squires, Kathleen E; Young, Benjamin; Santiago, Lizette; Dretler, Robin H; Walmsley, Sharon L; Zhao, Henry H; Pakes, Gary E; Ross, Lisa L; Shaefer, Mark S.

Afiliación

Squires KE; Thomas Jefferson University, Philadelphia, PA.
Young B; Apex Family Medicine and Research, Denver, CO.
Santiago L; International Association of Physicians in AIDS Care, Washington DC, USA.
Dretler RH; HOPE Clinic and Wellness Center, San Juan, Puerto Rico.
Walmsley SL; ID Specialists of Atlanta, Decatur, GA, USA.
Zhao HH; University Health Network, Toronto, ON, Canada.
Pakes GE; GlaxoSmithKline.
Ross LL; ViiV Healthcare, Research Triangle Park, NC, USA.
Shaefer MS; ViiV Healthcare, Research Triangle Park, NC, USA.

HIV AIDS (Auckl) ; 9: 51-61, 2017.

Article en En | MEDLINE | ID: mdl-28424561

Palabras clave

ARIES; HIV-infected; gender; virologic efficacy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Aspecto: Determinantes_sociais_saude Idioma: En Revista: HIV AIDS (Auckl) Año: 2017 Tipo del documento: Article País de afiliación: Panamá

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google